Abstract
In the present study the prognostic impact of new histological and molecular parameters were tested retrospectively in a series of 149 patients with esophageal squamous cell carcinoma (SCC) who underwent potentially curative resection therapy. In addition, the prognostic value of various molecular markers was investigated in a group of 38 patients with locally advanced esophageal SCC treated using combined therapy modalities. In the surgically treated carcinomas, the following morphological parameters proved to be prognostically significant in univariate survival analysis and multivariate survival analysis: pattern of invasion, inflammatory response, and lymph vessel invasion. In contrast, tumor grading according to the criteria of the WHO and tumor cell proliferation did not show significant prognostic impact. Concerning the prognostic influence of molecular parameters, strong expression of the proliferation regulating molecule p 21WAF 1 and weak expression of the apotosis regulating molecule Bcl-XL were predictors of poor survival in univariate and multivariate survival analysis. No prognostic impact was shown in relation to the expression of p 53 and the apoptosis regulating molecules Bcl-2 and Bax. In the multimodally treated esophageal cancer patients, strong expression of p 21WAF 1 and accumulation of p 53 were predictors of poor survival, whereas expression of Bcl-2, Bax, and Bcl-XL had no prognostic significance. In conclusion, morphological and molecular parameters may provide important prognostic information for esophageal cancer patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Al-Shenebner IF, Shibata HR, Sampalis J, Jothy S (1993) Prognostic significance of proliferating cell nuclear antigen expression in colorectal cancer. Cancer 71: 1954–1959
Cattoretti G, Becker MHG, Key G, Duchrow M, Schlüter C, Galle J, Gerdes J (1992) Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168: 357–363
Denham JW, Burmeister BH, Lamb DS, Spry NA, Joseph DJ, Hamilton CS, Yeoh E, O’Brien P, Walker QJ (1996) Factors influencing outcome following radio-chemotherapy for oesophageal cancer. Radiother Oncol 40: 31–43
Edwards JM, Hillier VF, Lawson RAM, Mousalli H, Hasleton PS (1989) Squamous carcinoma of the oesophagus: histologic criteria and their prognostic significance. Br J Cancer 59: 429–433
El-Deiry WS, Harper JW, O’Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrel M, Hill DE, Wang Y, Wiman KG, Mercer WE, Kastan MB, Kohn KW, El-ledge SJ, Kinzler KW, Vogelstein B (1994) WAF 1/CIP 1 is induced in p 53 mediated G 1 arrest and apoptosis. Cancer Res 54: 1169–1174
Forastiere AA, Heitmiller RF, Kleinberg L (1997) Multimodality therapy for esophageal cancer. Chest 112:195 S-200 S
Gabbert HE, Meier S, Gerharz CD, Hommel G (1991) Incidence and prognostic significance of vascular invasion in 529 gastric cancer patients. Int J Cancer 49: 203–207
Ilson DH, Kelsen DP (1994) Combined modality therapy in the treatment of esophageal cancer. Semin Oncol 21: 493–507
International Union Against Cancer (1992) TNM classification of malignant tumours, 4th edn, 2nd rev. Springer, Berlin Heidelberg New York
Japanese Society for Esophageal Diseases (1976) Guidelines for the clinical and pathologic studies on carcinoma of the esophagus. Jpn J Surg 6: 69–78
Jizuka T, Isono K, Kakegawa T, Watanabe H (1989) Parameters linked to ten-year survival in Japan of resected esophageal carcinoma. Chest 96: 1005–1011
Kato H, Tachimori Y, Watanabe H, Jizuka T (1993) Evaluation of the new (1987) TNM classification for thoracic esophageal tumors. Int J Cancer 53: 220–223
Kelsen DP (1997) Neoadjuvant therapy for esophageal cancer. Cancer J Sci Am 3: 137–139
Kitamura M, Sumiyoshi K, Sonoda K, Kitamura K, Tsutsui S, Toh Y, Kuwano H, Sugimachi K (1997) The clinical and histopathological contributing factors influencing the effectiveness of preoperative hyperthermo-chemo-radiotherapy for patients with esophageal cancer. Hepatogastroenterol 44: 175–180
Kubota Y, Petras RE, Easley KA, Bauer TW, Tubbs RR, Fazio VW (1992) Ki-67-determined growth fraction versus standard staging and grading parameters in colorectal carcinoma. Cancer 70: 2602–2609
Lee AKC, DeLellis RA, Silverman ML, Heatly GJ, Wolfe HJ (1990) Prognostic significance of peritumoral lymphatic and blood vessel invasion in node-negative carcinoma of the breast. J Clin Oncol 8: 1457–1463
Lowe SW (1995) Cancer therapy and p53. Curr Opin Oncol 7: 547–553
Railo M, Nordling S, von Boguslawski K, Leivonen M, Kyllonen L, von Smitten K (1993) Prognostic value of Ki-67 immunolabelling in primary operable breast cancer. Br J Cancer 68: 579–583
Reed JC, Miyashita T, Takayama S, Wang HG, Sato K, Krajewski S, Aime-Sempe C, Bofrug S, Kitada S, Hanada M (1996) BCL-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy. J Cell Biochem 60: 23–32
Roth JA, Lichter AS, Putnam JB Jr, Forastiere AA (1993) Cancer of the esophagus. In: DeVita VT Jr, Hellmann S, Rosenberg SA (eds) Cancer: principles and practice of oncology, 4th edn. Lippincott, Philadelphia, pp 776–817
Sarbia M, Porschen R, Borchard F, Horstmann O, Willers R, Gabbert HE (1994) p53 protein expression and prognosis in squamous cell carcinoma of the esophagus. Cancer 74: 2218–2223
Sarbia M, Bittinger F, Porschen R, Dutkowski P, Willers R, Gabbert HE (1995) Prognostic value of histopathologic parameters of esophageal squamous cell carcinoma. Cancer 76: 922–927
Sarbia M, Porschen R, Borchard F, Horstmann O, Willers R, Gabbert HE (1995) Incidence and prognostic significance of vascular and neural invasion in squamous cell carcinomas of the esophagus. Int J Cancer 61: 333–336
Sarbia M, Bittinger F, Porschen R, Dutkowski P, Torzewski M, Willers R, Gabbert HE (1996) The prognostic significance of tumour cell proliferation in squamous cell carcinomas of the oesophagus. Br J Cancer 74: 1012–1016
Sarbia M, Bittinger F, Grabellus F, Verreet P, Dutkowski P, Willers R, Gabbert HE (1997) Expression of Bax, a proapoptotic member of the Bd-2 family, in esophageal squamous cell carcinoma. Int J Cancer 73: 508–513
Stahl M, Wilke H, Fink U, Stuschke M, Walz MK, Siewert JR, Molls M, Fett W, Makoski HB, Breuer N, Schmidt U, Niebel W, Sack H, Eigler FW, Seeber S (1996) Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer; interim analysis of phase II trial. J Clin Oncol 14: 829–837
Strasser A, Huang DCS, Vaux DL (1997) The role of the bc1–2/ced-9 gene family in cancer and general applications of defects in cell death control for tumourigenesis and resistance to chemotherapy. Biochem Biophys Acta 1333: F151–F178
Sugimachi K, Matsuura H, Hidenobu K, Takashi K, Kiyoshi I, Jingu K (1986) Prognostic factors of esophageal carcinoma: univariate and multivariate analyses. J Surg Oncol 31: 108–112
Talbot IC, Ritchie S, Leighton MH, Hughes AO, Bussey HJR, Morson BC (1980) The clinical significance of invasion of veins by rectal cancer. Br J Surg 67: 439–442
Torzewski M, Sarbia M, Heep H, Dutkowski P, Willers R, Gabbert HE (1998) Expression of BcI-XL an antiapoptotic member of the Bd-2 family, in esophageal squamous cell carcinoma. Clin Cancer Res 4: 577–583
World Health Organization (1990) Histological typing of oesophageal and gastric tumours, 2nd edn. Springer, Berlin Heidelberg New York
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Sarbia, M., Gabbert, H.E. (2000). Modern Pathology: Prognostic Parameters in Squamous Cell Carcinoma of the Esophagus. In: Lange, J., Siewert, J.R. (eds) Esophageal Carcinoma. Recent Results in Cancer Research, vol 155. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59600-1_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-59600-1_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64044-5
Online ISBN: 978-3-642-59600-1
eBook Packages: Springer Book Archive